Volume 12, Number 12—December 2006
Dispatch
Drug Trafficking Routes and Hepatitis B in Injection Drug Users, Manipur, India
Sibnarayan Datta*, Arup Banerjee*, Partha K. Chandra*, Pradip K. Mahapatra†, Shekhar Chakrabarti‡, and Runu Chakravarty*
Table
Serum HBV DNA levels and amino acid variability in the partial s gene, including the region encoding the major hydrophillic loop, compared with consensus sequences*
| Isolate | Serum HBV DNA (×103 copies/mL) | 110† | 113† | 114† | 122‡ | 126† | 131† | 134† | 143† | 145 | 159† | 160‡ | 161† | 163 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cn A | – | I | S | T | K | T | N | F | T | G | A | K | Y | W |
| Cn D | – | – | – | S | – | – | T | Y | S | – | G | – | F | – |
| Cn C | – | L | T | S | – | I | T | – | S | – | – | R | F | – |
| IDU1 | ND | – | – | – | – | – | – | – | S | – | G | – | F | – |
| IDU2 | ND | – | – | – | – | – | – | – | – | – | – | – | F | – |
| IDU3 | 45.0 | – | – | – | – | – | T | – | S | – | – | – | F | – |
| IDU4 | 14.0 | L | – | S | – | I | T | – | S | – | – | R | F | – |
| IDU5 | 1.05 | L | T | S | – | I | – | – | S | – | – | – | F | – |
| IDU6 | ND | L | T | S | – | I | T | – | S | R | – | R | F | R |
| IDU7 | ND | L | T | S | – | I | T | – | S | R | T | R | F | R |
| IDU8 | 9.0 | L | T | S | – | I | T | – | S | – | – | R | F | – |
| IDU9 | ND | L | T | S | – | I | T | – | S | – | – | R | F | – |
| IDU10 | 64.0 | L | T | S | – | I | T | – | S | – | – | R | F | –
*Indicated by Cn, followed by genotype. HBV, hepatitis B virus; IDU, injection drug user; ND, not detectable by the assay. |
*Indicated by Cn, followed by genotype. HBV, hepatitis B virus; IDU, injection drug user; ND, not detectable by the assay.
†Genotype-specific sites.
‡Subtype-specific sites.
